Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aiach

Showing results (131-140 of 236) with videos related to

Pageof 24
Sort By:
Thrombosis and Haemostasis|January 12, 2001
The FXIII Val 34 Leu mutation and the risk of venous thrombosisM Alhenc-Gelas, J L Reny, M L Aubry, et al.
La Nouvelle Presse Medicale|April 26, 1980
[Current aspects of the treatment of deep venous thromboses by heparin (author's transl)]Y Juillet, D Morin, A Richard, et al.
The Journal of Cardiovascular Surgery|March 1, 1981
Streptokinase after late failure of reconstructive surgery for peripheral arteriosclerosisJ M Husson, J N Fiessinger, M Aiach, et al.
Seminars in Hematology|July 1, 1997
Protein C and protein S deficienciesM Aiach, D Borgel, P Gaussem, et al.
Thrombosis and Haemostasis|May 6, 1998
Thrombomodulin modulates the mitogenic response to thrombin of human umbilical vein endothelial cellsM Lafay, R Laguna, B F Le Bonniec, et al.
Thrombosis Research|September 1, 1985
A functional abnormal antithrombin III (AT III) deficiency: AT III CharlevilleM Aiach, M Nora, J N Fiessinger, et al.
Haemostasis|January 1, 1984
Low molecular weight (LMW) heparin derivatives in experimental extra-corporeal circulation (ECC)M Aiach, G Dreyfus, A Michaud, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Genetic diagnosis of qualitative and quantitative antithrombin III deficienciesE Clauser, S Gandrille, D Vidaud, et al.
Pathologie-Biologie|December 1, 1977
[Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)]M Aiach, J N Fiessinger, J P Andreux, et al.
Presse Medicale (Paris, France : 1983)|June 7, 1986
[Heparin therapy: changing from the venous to the subcutaneous route]J F Vitoux, C Leroy, T Lecompte, et al.
Pageof 24

Showing results (131-140 of 236) with videos related to

Sort By:
Pageof 24
Thrombosis and Haemostasis|January 12, 2001
The FXIII Val 34 Leu mutation and the risk of venous thrombosisM Alhenc-Gelas, J L Reny, M L Aubry, et al.
La Nouvelle Presse Medicale|April 26, 1980
[Current aspects of the treatment of deep venous thromboses by heparin (author's transl)]Y Juillet, D Morin, A Richard, et al.
The Journal of Cardiovascular Surgery|March 1, 1981
Streptokinase after late failure of reconstructive surgery for peripheral arteriosclerosisJ M Husson, J N Fiessinger, M Aiach, et al.
Seminars in Hematology|July 1, 1997
Protein C and protein S deficienciesM Aiach, D Borgel, P Gaussem, et al.
Thrombosis and Haemostasis|May 6, 1998
Thrombomodulin modulates the mitogenic response to thrombin of human umbilical vein endothelial cellsM Lafay, R Laguna, B F Le Bonniec, et al.
Thrombosis Research|September 1, 1985
A functional abnormal antithrombin III (AT III) deficiency: AT III CharlevilleM Aiach, M Nora, J N Fiessinger, et al.
Haemostasis|January 1, 1984
Low molecular weight (LMW) heparin derivatives in experimental extra-corporeal circulation (ECC)M Aiach, G Dreyfus, A Michaud, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Genetic diagnosis of qualitative and quantitative antithrombin III deficienciesE Clauser, S Gandrille, D Vidaud, et al.
Pathologie-Biologie|December 1, 1977
[Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)]M Aiach, J N Fiessinger, J P Andreux, et al.
Presse Medicale (Paris, France : 1983)|June 7, 1986
[Heparin therapy: changing from the venous to the subcutaneous route]J F Vitoux, C Leroy, T Lecompte, et al.
Pageof 24